STOMACH NEOPLASMS

Clinical trials for STOMACH NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new STOMACH NEOPLASMS trials appear

Sign up with your email to follow new studies for STOMACH NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 21 Not yet recruiting 5 Not yet finished but already full! 1 Completed 4

Experimental drug duo targets Hard-to-Treat HER2 cancers

Disease control Ongoing

This study tests two drugs together—disitamab vedotin and tucatinib—in people with advanced breast or stomach cancers that have a protein called HER2. The goal is to see if the combination is safe and shrinks tumors. About 172 participants will take part.

Matched conditions: STOMACH NEOPLASMS

Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC

STOMACH NEOPLASMS

Get alerted when new STOMACH NEOPLASMS trials appear

Experimental drug duo targets Hard-to-Treat HER2 cancers